The physiological limits of bispecific monoclonal antibody tissue targeting specificity

Bispecific monoclonal antibodies (bsmAbs) are expected to provide targeted drug delivery that overcomes the dose-limiting toxicities often accompanying antibody-drug conjugates (ADC) in clinical practice. Much attention has been paid in the past to target selection, mAb affinities and the payload li...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Armin Sepp, Felix Stader, Abdallah Derbalah, Cong Liu, Adriana Zyla, Iain Gardner, Masoud Jamei
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	mAbs
Assuntos:	Monoclonal antibody bispecific antibody antibody-drug conjugate physiologically-based pharmacokinetics EGFR HER2
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/19420862.2025.2492236
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!